Wesbanco Bank Inc Mannkind Corp Transaction History

Wesbanco Bank Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 13, 2019	SELL	$1.09 - $1.88 $59,950 - $103,400	-55,000 Closed	0 $0
Q3 2018 Nov 09, 2018	BUY	$1.01 - $2.19 $10,100 - $21,900	10,000 Added 22.22%	55,000 $101,000
Q2 2018 Aug 08, 2018	BUY	$1.59 - $2.38 $38,478 - $57,596	24,200 Added 116.35%	45,000 $86,000
Q1 2018 May 18, 2018	BUY	$2.28 - $3.8 $47,423 - $79,040	20,800 New	20,800 $47,000

219

133M

1.43M

851K

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.6B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

Get notified when there are updates to the investment portfolio of Wesbanco Bank Inc, based on Form 13F filings with the SEC.

Stay updated on Wesbanco Bank Inc with notifications on news.